Skip to main content
OpenTrials

Clinical trial condition

Genital Herpes Simplex Type 2

Explore clinical trials studying Genital Herpes Simplex Type 2. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Genital Herpes Simplex Type 2 trial results

Active, not recruiting

A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions

NCT05432583

Conditions
Genital Herpes Simplex Type 2
Locations
  • Alliance for Multispecialty Research, LLC Tempe, Arizona, United States
  • Great Lakes Clinical Trials - Flourish Research Chicago, Illinois, United States
  • Accellacare Raleigh Medical Group Raleigh, North Carolina, United States
  • Accellacare PMG Research Wilmington LLC Wilmington, North Carolina, United States
View Trial Details
Completed

Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults

NCT02030301

Conditions
DNA Virus Infections, Genital Herpes Simplex Type 2, Herpes Simplex, +7 more
Locations
  • Alabama Vaccine Research Clinic Birmingham, Alabama, United States
  • Broward Research Group Hollywood, Florida, United States
  • Indiana University Infectious Diseases Research Indianapolis, Indiana, United States
  • Westover Heights Clinic Portland, Oregon, United States
View Trial Details
Completed

Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine

NCT01667341

Conditions
DNA Virus Infections, Genital Herpes Simplex Type 2, Herpes Simplex, +7 more
Locations
  • University of Alabama Vaccine Research Unit Birmingham, Alabama, United States
  • Indiana University Infectious Disease Research Indianapolis, Indiana, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Westover Heights Clinic Portland, Oregon, United States
View Trial Details
Completed

Evaluating New Formulation of Therapeutic HSV-2 Vaccine

NCT02515175

Conditions
Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +18 more
Locations
  • University of Alabama-Birmingham Birmingham, Alabama, United States
  • Medical Center for Clinical Research San Diego, California, United States
  • Quest Clinical Research San Francisco, California, United States
  • The Fenway Institute Boston, Massachusetts, United States
View Trial Details
Completed

Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity

NCT02910284

Conditions
Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +18 more
Locations
  • University of Alabama - Birmingham Birmingham, Alabama, United States
  • Medical Center for Clinical Research San Diego, California, United States
  • Quest Clinical Research San Francisco, California, United States
  • University of Illinois - Chicago Chicago, Illinois, United States
View all 13 locations
View Trial Details
Completed

Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine

NCT02114060

Conditions
DNA Virus Infections, Genital Herpes Simplex Type 2, Herpes Simplex, +7 more
Locations
  • University of Alabama Vaccine Research Unit Birmingham, Alabama, United States
  • Medical Center for Clinical Research San Diego, California, United States
  • Quest Clinical Research San Francisco, California, United States
  • University of Illinois Department of Medicine Chicago, Illinois, United States
View all 16 locations
View Trial Details
Completed

Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study

NCT02300142

Conditions
DNA Virus Infections, Genital Herpes Simplex Type 2, Herpes Simplex, +7 more
Locations
  • University of Alabama Vaccine Research Unit Birmingham, Alabama, United States
  • Medical Center for Clinical Research San Diego, California, United States
  • Quest Clinical Research San Francisco, California, United States
  • University of Illinois Department of Medicine Chicago, Illinois, United States
View all 16 locations
View Trial Details

Related conditions